Ovarian Cancer State of the Art and Future Directions in Translational Research /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2008.
|
| Edición: | 1st ed. 2008. |
| Colección: | Advances in Experimental Medicine and Biology,
622 |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-0-387-68969-2 |
Tabla de Contenidos:
- Ovarian Cancer Detection and Pathogenesis
- Potential and Limitations in Early Diagnosis of Ovarian Cancer
- SMRP and HE4 as Biomarkers for Ovarian Carcinoma When Used Alone and in Combination with CA125 and/or Each Other
- Classification of Ovarian Cancer: A Genomic Analysis
- Epigenetic Markers of Ovarian Cancer
- Role of Genetic Polymorphisms in Ovarian Cancer Susceptibility: Development of an International Ovarian Cancer Association Consortium
- MicroRNA in Human Cancer: One Step Forward in Diagnosis and Treatment
- Ovarian Carcinogenesis: An Alternative Hypothesis
- BRCA1-Induced Ovarian Oncogenesis
- Role of p53 and Rb in Ovarian Cancer
- Ovulatory Factor in Ovarian Carcinogenesis
- Ovarian Cancer Therapeutics
- Gynecologic Oncology Group (GOG-USA) Trials in Ovarian Cancer
- Intraperitoneal Chemotherapy for Ovarian Cancer
- Ovarian Cancer: Can We Reverse Drug Resistance?
- Syngeneic Mouse Model of Epithelial Ovarian Cancer: Effects of Nanoparticulate Paclitaxel, Nanotax®
- Individualized Molecular Medicine: Linking Functional Proteomics to Select Therapeutics Targeting the PI3K Pathway for Specific Patients
- Defective Apoptosis Underlies Chemoresistance in Ovarian Cancer
- Nanoparticle Delivery of Suicide DNA for Epithelial Ovarian Cancer Therapy
- Biological Therapy with Oncolytic Herpesvirus
- Cancer Immunotherapy: Perspectives and Prospects
- Regulatory T Cells: A New Frontier in Cancer Immunotherapy
- Inhibitory B7 Family Members in Human Ovarian Carcinoma
- Role of Vascular Leukocytes in Ovarian Cancer Neovascularization
- Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a New Target Molecule for Cancer Therapy.